Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Avatrombopag for chronic immune thrombocytopenia in Chinese adults
CTR20210431Phase 3Completed
- Sponsor
- AkaRx
- Start
- Mar 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of avatrombopag in chronic primary immune thrombocytopenia (ITP), sponsored by AkaRx. Started Mar 2021; status: completed.
02
Drugs
avatrombopag
03
Conditions
chronic primary immune thrombocytopenia (ITP)
Beyond the preview
Go deeper on CTR20210431.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20210431.